Lightbridge Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity and StockBased Compensation (Details Narrative)

Stockholders Equity and StockBased Compensation (Details Narrative) - USD ($)			1 Months Ended				3 Months Ended	9 Months Ended
	Dec. 03, 2021	Apr. 09, 2021	Nov. 19, 2021	Nov. 18, 2021	Oct. 29, 2021	Jun. 30, 2016	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Mar. 25, 2021
Increased In Common Stock Shares Authorized							188,588	188,588		188,588
Convertible Restricted Stock							188,588	188,588		188,588
Stock Options Outstanding							12,254,423	12,254,423		10,532,101
Common Stock, Shares Outstanding							11,539,932	11,539,932		9,759,223
Restricted stock award not included outstanding shares							188,588	188,588		188,588
Common Stock, Shares Issued							11,539,932	11,539,932		9,759,223
Preferred Stock, Shares Outstanding							0	0		0
Issuance Of Stock Option								0
Exchange Of Outstanding Series A Convertible Preferred Stock For Common Shares [Member]
Additional Common Stock Shares Issuable	232,111				183,098
Closing Stock Price	$ 7.57				$ 9.57
Additional Paid-in Capital A Deemed Dividend	$ 1,800,000				$ 1,800,000
Conversion of preferred share to common share					262,910
Available-for-sale Securities [Member]
Agreement To Sale Of Company's Securities											$ 75,000,000
Aggregate Offering Price		$ 9,000,000.0	$ 20,000,000.0
Non-vested stock options [Member]
Net Unrecognized Compensation Cost							$ 48,000	$ 48,000
Recognized Weighted-average Period								2 years 3 months 3 days
Vested Stock Options [Member]
Aggregate Intrinsic Value							$ 54,000	$ 54,000
New Atm Agreement [Member]
Sold Of Atm							500,000	1,800,000	600,000
Proceeds For Sale Of Atm							$ 3,000,000.0	$ 10,600,000	$ 3,400,000
Short Term Non Qualified Option [Member] \| Advisory Board [Member] \| Directors Officers And Employees [Member]
Non-qualified Stock Options Granted								339,855
Term Of Options								10 years
Common Stocks
Common Stock, Shares Issued							543,297	543,297		538,713
Common Share Issuances [Member]
Common Stock, Shares Issued							7,276	7,276	7,382
Series B Preferred Stock [Member] \| Convertible Stock [Member]
Preferred Stock, Shares Outstanding							2,666,667	2,666,667
Liquidation Preference Per Share							$ 10.00	$ 10.00
Issued To Investors On November 17, 2014 [Member]
Warrants Outstanding, Total							45,577	45,577		45,577
Purchase Common Shares								45,577
Exercise Price								$ 138.60
Reducedexercise Price						$ 75.00
Consultants [Member]
Exercise Price								$ 3.98
Issuance Of Stock Option								18,852
Non-qualified Stock Options Granted								180,710
Consultants [Member] \| Minimum [Member]
Contractual Lives								7 months 9 days
Term Of Options								2 years
Exercise Price								$ 3.82
Consultants [Member] \| Maximum [Member]
Contractual Lives								9 years 11 months 1 day
Term Of Options								10 years
Exercise Price								$ 75.60
Chief Executive Officer [Member] \| Short Term Non Qualified Option [Member] \| Advisory Board [Member]
Non-qualified Stock Options Outstanding								127,299
Chief Executive Officer [Member] \| Short Term Non Qualified Option [Member] \| Minimum [Member] \| Advisory Board [Member]
Exercise Price								$ 3.82
Contractual Lives								2 years 6 months 7 days
Chief Executive Officer [Member] \| Short Term Non Qualified Option [Member] \| Maximum [Member] \| Advisory Board [Member]
Exercise Price								$ 75.60
Contractual Lives								7 years 2 months 1 day
Board of Directors Chairman [Member] \| Restricted Stock Awards [Member]
Additional Common Shares				188,588			188,588	188,588		188,588
Common Shares Issuances Equity Grant Value				$ 2,000,000				$ 2,000,000.0
Common Shares Equity Grant Price Per Shares				$ 10.69				$ 10.69
Description Of Common Shares Issuances				These 188,588 RSAs were not included in the total outstanding common shares, on the accompanying balance sheets and changes in statements of stockholders’ equity at September 30, 2022 and December 31, 2021. The Company has been assessing the probability of achieving this performance condition at each reporting period in 2022 and will record the $2 million as an expense as well as include these performance-based RSAs in the total outstanding common shares, if there is a change to management’s assessment that it is probable that this performance-condition will be met				These 188,588 shares were included in the total outstanding common shares at September 30, 2022 and December 31, 2021 and compensation expense will be recognized straight line over the three-year vesting period. A total of $0.5 million of compensation expense was recorded for the nine months ended September 30, 2022
Total Unrecognized Compensation Cost							$ 1,400,000	$ 1,400,000
Weighted-average period								2 years 1 month 17 days
General International Holdings, Inc [Member]
Conversion Price					$ 10
Issued Of Aggregate Shares Of Common Stock	522,244